Advisor Group Holdings, Inc. Chembio Diagnostics, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$2.06 - $5.34 $206 - $534	-100 Reduced 8.0%	1,150 $3,000
Q1 2021 May 13, 2021	SELL	$3.4 - $7.97 $6,800 - $15,940	-2,000 Reduced 61.54%	1,250 $4,000
Q4 2020 Feb 10, 2021	SELL	$4.11 - $7.51 $2,055 - $3,755	-500 Reduced 13.33%	3,250 $15,000
Q3 2020 Nov 12, 2020	SELL	$3.28 - $5.93 $1,577 - $2,852	-481 Reduced 11.37%	3,750 $18,000
Q2 2020 Aug 14, 2020	BUY	$3.18 - $15.54 $9,063 - $44,289	2,850 Added 206.37%	4,231 $15,000
Q1 2020 May 18, 2020	BUY	$2.36 - $5.6 $3,259 - $7,733	1,381 New	1,381 $7,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.